Ms Suraj Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -7.04%
- Profit Growth 0.56%
- Ebitda -3.09%
- Net Worth 12.63%
- Total Assets -2.72%
About Ms Suraj Pharmaceuticals (India)
Ms Suraj Pharmaceuticals (India) Private Limited (MSPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 July 2014 and has a history of Ten years and seven months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shambhu Verma and Mala Rani serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232BR2014PTC022481
-
Company No.
022481
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jul 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Ms Suraj Pharmaceuticals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shambhu Verma
|
Director | 03-Jul-2014 | Current |
|
Mala Rani
|
Director | 03-Jul-2014 | Current |
Financial Performance of Ms Suraj Pharmaceuticals (India).
Ms Suraj Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.04% decrease. The company also saw a slight improvement in profitability, with a 0.56% increase in profit. The company's net worth Soared by an impressive increase of 12.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ms Suraj Pharmaceuticals (India)?
In 2023, Ms Suraj Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ms Suraj Pharmaceuticals (India)?
Unlock and access historical data on people associated with Ms Suraj Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ms Suraj Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ms Suraj Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.